Clinical trial
SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis
NCT02696941 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis
- Lead sponsor
- University of Oxford
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- April 1, 2018
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.